FDA Denies Macular Degeneration Claims For Lutein, Branded Or Not
This article was originally published in The Tan Sheet
FDA extended its denial of Cognis' qualified health claim petition for Xangold branded lutein esters to other forms of the nutrient, including zeaxanthin, the agency announced in a recent communication to the ingredient supply firm
You may also be interested in...
FDA may look to health claim statements developed and tested by FTC as it continues working toward effective use of the claims in product labeling, Deputy Commissioner for Medical & Scientific Affairs Scott Gottlieb, MD, indicated during a recent speech to industry
Cognis Nutrition & Health is petitioning FDA for a qualified health claim linking its Xangold Natural Lutein Esters to a reduced risk of age-related macular degeneration (AMD) and cataracts
The global scope of food safety is becoming apparent, and recent problems with products imported from China are but a part of U.S. food safety concerns, industry experts say